Medical 24 Limited - Limited company accounts 11.7
Medical 24 Limited - Limited company accounts 11.7
REGISTERED NUMBER: |
Strategic Report, Report of the Directors and |
Financial Statements for the Year Ended 30 September 2015 |
for |
Medical 24 Limited |
Medical 24 Limited (Registered number: 08705888) |
Contents of the Financial Statements |
for the Year Ended 30 September 2015 |
Page |
Company Information | 1 |
Strategic Report | 2 |
Report of the Directors | 3 |
Report of the Independent Auditors | 5 |
Profit and Loss Account | 6 |
Balance Sheet | 7 |
Cash Flow Statement | 8 |
Notes to the Cash Flow Statement | 9 |
Notes to the Financial Statements | 10 |
Medical 24 Limited |
Company Information |
for the Year Ended 30 September 2015 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
STATUTORY AUDITORS |
Medical 24 Limited (Registered number: 08705888) |
Strategic Report |
for the Year Ended 30 September 2015 |
The directors present their strategic report for the year ended 30 September 2015. |
REVIEW OF BUSINESS |
The directors consider that the profit achieved on ordinary activities before taxation to be extremely satisfactory. The |
directors are particularly pleased that a large increase in turnover has been achieved. |
2015 2014 |
Turnover £ 8,012,542 £2,212,165 |
Turnover growth £5,800,377 £2,212,165 |
Gross profit margin 30% 30% |
Profit before tax 16% 16% |
PRINCIPAL RISKS AND UNCERTAINTIES |
Medical 24 Limited had an excellent year considering it is only the second period of trading. The company mainly |
provide staff to the healthcare sector and there is a strong demand in this area, despite the current economic |
conditions.The directors are aware of the need to monitor costs and have put strategies in place to achieve continued |
growth and maintain profitability. Adequate finance is in place to take advantage of business opportunities as they arise. |
ON BEHALF OF THE BOARD: |
Medical 24 Limited (Registered number: 08705888) |
Report of the Directors |
for the Year Ended 30 September 2015 |
The directors present their report with the financial statements of the company for the year ended 30 September 2015. |
DIVIDENDS |
No interim dividends were paid during the year ended 30 September 2015. |
The directors recommend final dividends per share as follows: |
Ordinary £1 shares | £3,669 |
A Ordinary £1 shares | NIL |
The total distribution of dividends for the year ended 30 September 2015 will be £ 366,869 . |
DIRECTORS |
The directors shown below have held office during the whole of the period from 1 October 2014 to the date of this |
report. |
STATEMENT OF DIRECTORS' RESPONSIBILITIES |
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with |
applicable law and regulations. |
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors |
have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting |
Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not |
approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the |
company and of the profit or loss of the company for that period. In preparing these financial statements, the directors |
are required to: |
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
- | state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; |
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the |
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and |
enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for |
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud |
and other irregularities. |
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act |
2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken |
as a director in order to make himself aware of any relevant audit information and to establish that the company's |
auditors are aware of that information. |
Medical 24 Limited (Registered number: 08705888) |
Report of the Directors |
for the Year Ended 30 September 2015 |
AUDITORS |
The auditors, SHERIDAN CLARKE LTD, will be proposed for re-appointment at the forthcoming Annual General |
Meeting. |
ON BEHALF OF THE BOARD: |
Report of the Independent Auditors to the Members of |
Medical 24 Limited |
We have audited the financial statements of Medical 24 Limited for the year ended 30 September 2015 on pages six to |
fourteen. The financial reporting framework that has been applied in their preparation is applicable law and United |
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). |
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the |
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those |
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent |
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's |
members as a body, for our audit work, for this report, or for the opinions we have formed. |
Respective responsibilities of directors and auditors |
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors. |
Scope of the audit of the financial statements |
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give |
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. |
This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and |
have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by |
the directors; and the overall presentation of the financial statements. In addition, we read all the financial and |
non-financial information in the Strategic Report and the Report of the Directors to identify material inconsistencies with |
the audited financial statements and to identify any information that is apparently materially incorrect based on, or |
materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of |
any apparent material misstatements or inconsistencies we consider the implications for our report. |
Opinion on financial statements |
In our opinion the financial statements: |
- | give a true and fair view of the state of the company's affairs as at 30 September 2015 and of its profit for the year then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
Opinion on other matter prescribed by the Companies Act 2006 |
In our opinion the information given in the Strategic Report and the Report of the Directors for the financial year for |
which the financial statements are prepared is consistent with the financial statements. |
Matters on which we are required to report by exception |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you |
if, in our opinion: |
- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of directors' remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit. |
for and on behalf of |
STATUTORY AUDITORS |
Medical 24 Limited (Registered number: 08705888) |
Profit and Loss Account |
for the Year Ended 30 September 2015 |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
Notes | £ | £ |
TURNOVER |
Cost of sales |
GROSS PROFIT |
Administrative expenses |
OPERATING PROFIT and |
PROFIT ON ORDINARY ACTIVITIES BEFORE TAXATION |
3 |
Tax on profit on ordinary activities | 4 |
PROFIT FOR THE FINANCIAL YEAR |
CONTINUING OPERATIONS |
None of the company's activities were acquired or discontinued during the current year or previous period. |
TOTAL RECOGNISED GAINS AND LOSSES |
The company has no recognised gains or losses other than the profits for the current year or previous period. |
Medical 24 Limited (Registered number: 08705888) |
Balance Sheet |
30 September 2015 |
30.9.15 | 30.9.14 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 6 |
CURRENT ASSETS |
Debtors | 7 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 10 |
Profit and loss account | 11 |
SHAREHOLDERS' FUNDS | 13 |
The financial statements were approved by the Board of Directors on |
Medical 24 Limited (Registered number: 08705888) |
Cash Flow Statement |
for the Year Ended 30 September 2015 |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
Notes | £ | £ |
Net cash inflow/(outflow) |
from operating activities | 1 | 1,179,205 | (33,311 | ) |
Taxation | ( |
) |
Capital expenditure | 2 | - | (7,753 | ) |
Equity dividends paid | (366,869 | ) | - |
731,239 | (41,064 | ) |
Financing | 2 | 40 | 100 |
Increase/(decrease) in cash in the period | ( |
) |
Reconciliation of net cash flow |
to movement in net debt | 3 |
Increase/(decrease) in cash in the period | ( |
) |
Change in net debt resulting |
from cash flows | ( |
) |
Movement in net debt in the period | ( |
) |
Net debt at 1 October | ( |
) |
Net funds/(debt) at 30 September | ( |
) |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Cash Flow Statement |
for the Year Ended 30 September 2015 |
1. | RECONCILIATION OF OPERATING PROFIT TO NET CASH INFLOW/(OUTFLOW) FROM OPERATING ACTIVITIES |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Operating profit |
Depreciation charges | 1,451 | 1,938 |
Increase in debtors | (200,746 | ) | (552,533 | ) |
Increase in creditors | 53,220 | 147,736 |
Net cash inflow/(outflow) from operating activities | 1,179,205 | (33,311 | ) |
2. | ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE CASH FLOW STATEMENT |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Capital expenditure |
Purchase of tangible fixed assets | - | (7,753 | ) |
Net cash outflow for capital expenditure | - | (7,753 | ) |
Financing |
Share issue | 40 | 100 |
Net cash inflow from financing | 40 | 100 |
3. | ANALYSIS OF CHANGES IN NET DEBT |
At | At |
1.10.14 | Cash flow | 30.9.15 |
£ | £ | £ |
Net cash: |
Cash at bank | 635,022 |
Bank overdraft | ( |
) | 96,257 |
(40,964 | ) | 690,315 |
Total | ( |
) |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements |
for the Year Ended 30 September 2015 |
1. | ACCOUNTING POLICIES |
Accounting convention |
The financial statements have been prepared under the historical cost convention and are in accordance with |
applicable accounting standards. |
Turnover |
Turnover comprises the invoiced value of services supplied by the company, all revenue is recognised in the |
Financial Statements as soon as the service has been supplied. |
Tangible fixed assets |
Fixtures and fittings | - |
Taxation |
Current tax, including UK Corporation tax is provided at amounts expected to be paid using the tax rates and |
laws enacted by the Balance Sheet date. |
Deferred tax is only provided for when material. The Director's have decided that deferred tax is not material this |
year, as was the case last year. |
2. | STAFF COSTS |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Wages and salaries |
Social security costs |
The average monthly number of employees during the year was as follows: |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
Administration | 3 | 1 |
Sales | 10 | 7 |
13 | 8 |
3. | OPERATING PROFIT |
The operating profit is stated after charging: |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Depreciation - owned assets |
Auditors' remuneration |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2015 |
3. | OPERATING PROFIT - continued |
Directors' remuneration |
Information regarding the highest paid director for the year ended 30 September 2015 is as follows: |
Year Ended |
30.9.15 |
£ |
Emoluments etc |
4. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit on ordinary activities for the year was as follows: |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Current tax: |
UK corporation tax |
Tax on profit on ordinary activities |
Factors affecting the tax charge |
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is |
explained below: |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Profit on ordinary activities before tax |
Profit on ordinary activities |
multiplied by the standard rate of corporation tax |
in the UK of |
Effects of: |
Expenses not deductible for tax purposes |
Capital allowances in excess of depreciation | - | ( |
) |
Depreciation in excess of capital allowances | - |
Current tax charge |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2015 |
5. | DIVIDENDS |
Period |
25.9.13 |
Year Ended | to |
30.9.15 | 30.9.14 |
£ | £ |
Ordinary shares of £1 each |
Final | 366,869 | - |
6. | TANGIBLE FIXED ASSETS |
Fixtures |
and |
fittings |
£ |
COST |
At 1 October 2014 |
and 30 September 2015 |
DEPRECIATION |
At 1 October 2014 |
Charge for year |
At 30 September 2015 |
NET BOOK VALUE |
At 30 September 2015 |
At 30 September 2014 |
7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.9.15 | 30.9.14 |
£ | £ |
Trade debtors | 753,139 | 552,433 |
Other debtors | 140 | 100 |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.9.15 | 30.9.14 |
£ | £ |
Bank loans and overdrafts (see note 9) |
Trade creditors |
Tax |
Social security and other taxes |
Other creditors |
Accrued expenses | 12,042 | 2,524 |
See note 12 for details regarding Related Parties in other creditors. |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2015 |
9. | LOANS |
An analysis of the maturity of loans is given below: |
30.9.15 | 30.9.14 |
£ | £ |
Amounts falling due within one year or on demand: |
Bank overdrafts |
10. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30.9.15 | 30.9.14 |
value: | £ | £ |
A Ordinary | £1 |
Allotted and issued: |
Number: | Class: | Nominal | 30.9.15 | 30.9.14 |
value: | £ | £ |
Share capital 1 | £1 |
11. | RESERVES |
Profit |
and loss |
account |
£ |
At 1 October 2014 |
Profit for the year |
Dividends | ( |
) |
At 30 September 2015 |
12. | RELATED PARTY DISCLOSURES |
K. Coyle, C. Coyle, D. Harrington, N. Poturicich and C. Safapour are also Directors of Mayday Healthcare Plc, |
Mayday Direct 24 Plc, Plan B Healthcare Plc, VIP Nursing Limited and Pro Health 24 Limited. Further, K. |
Coyle and D. Harrington are also Directors of Coyle Personnel Plc. At the year end, the company owed Coyle |
Personnel Plc £1,042, 2014 £ 24 and Mayday Healthcare Plc £577, 2014 £ 12,529 for services supplied, these |
amounts have now been paid. |
No trading has been carried out between any of the Related Parties. Kevin Coyle holds the controlling interest in |
the company by virtue of ownership of 80% of the shares, his son Christopher owns the remaining 20%. All |
dividends were paid to shareholder Directors. |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2015 |
13. | RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS |
30.9.15 | 30.9.14 |
£ | £ |
Profit for the financial year |
Dividends | ( |
) |
New share capital subscribed | 40 | 100 |
Net addition to shareholders' funds |
Opening shareholders' funds |
Closing shareholders' funds |